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Local orientational disorder in peptide fibrils probed by a 
combination of residue-specific 13C-18O labelling, polarised infrared 
spectroscopy and molecular combing 
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A novel combination of site-specific isotope labelling, polarised infrared spectroscopy and 
molecular combing reveal local orientational ordering in the fibril-forming peptide 
YTIAALLSPYSGGRADS. Use of 13C-18O labelled alanine residues demonstrates that the N-
terminal end of the peptide is incorporated into the cross-beta structure, while the C-terminal end 
shows orientational disorder 
Many different proteins and peptides self-assemble into “amyloid” fibrils. Such fibrils are associated with 
a range of diseases;1 in addition, self-assembly of other proteins and designed peptides raises the 
possibility of their use as potential nanomaterials.2 Amyloid fibrils share a common core “cross-β” 
structure, as demonstrated by fiber X-ray diffraction,3 where strands are arranged perpendicular to the 
fibril, held together in sheets by hydrogen-bonding between NH and CO groups with bonds running up 
and down the fibril axis. It is very difficult to obtain more detailed structural information on polypeptide 
conformation within different fibrils, because in general they are not amenable to analysis by x-ray 
crystallography. 
Infrared linear dichroism (IRLD) uses plane polarized IR light to provide orientational information on the 
vibrating dipole moments in oriented samples.4 There are several previous examples of the use of 
polarized infrared spectroscopy to obtain orientational information relative to the long axis of protein 
fibres. These include the work of Ambrose and Elliott5 and Burke and Rougvie6, who investigated films 
of fibrous insulin samples, and Hiramatsu and coworkers,7 who studied fibrils formed from the protein 
β2-microglobulin and synthetic peptides based on its sequence, using IRLD microscopy on oriented 
particles within pellets. Recently we have developed the technique of molecular combing to produce 
reproducible oriented films of amyloid fibrils from hen lysozyme and model peptides.8  IRLD on oriented 
amyloid samples gives an Amide I band at around 1630 cm-1 polarised parallel to the fibril axis, 
confirming the cross-β strand conformation.5-6 In some cases, a higher-frequency peak with orthogonal 
polarisation is seen, demonstrating the anti-parallel configuration.7b, 8  
These experiments only give information averaged over the entire protein or peptide, and do not give 
residue-specific information on backbone conformation. Site-specific data may be obtained with 
vibrational spectroscopy using isotope labelling, also known as isotope editing, as the change in reduced 
mass causes a shift in frequency for the labelled site. The combination of isotope labelling with IRLD has 
been carried out on peptide crystals9 and membrane proteins in oriented bilayers.10 In this latter work, the 
Arkin group has pioneered the use of the 13C-18O label described in this Communication, to determine the 
orientation of a specific carbonyl group relative to the bilayer normal in membrane-bound proteins. 
Although labels on unoriented amyloid fibril samples have been used to demonstrate local interactions 
with standard11 and 2D12 IR, no IRLD experiments have thus far been performed on labelled amyloid 
fibrils. Here, we demonstrate the incorporation of a 13C-18O label into a 17-residue peptide, fibrils of 
which were oriented using molecular combing methods recently developed in our group.8 The data 
obtained are used to probe local orientational ordering. 
The peptide YTIAALLSPYSGGRADS has been studied as control for YTIAALLSPYSGGRGDS, which 
was designed to exhibit the RGD cell-binding motif on the fibril surface.13 In this application, it is 
important that the C-terminus is flexible, so that it can interact with cell surface integrin receptors, while 
the N-terminus assembles into cross-beta fibrils. Residues 1-11 of the peptide sequence were taken from 
residues 105-115 of transthyretin, a known amyloidogenic protein,14 and the GG linker chosen to add 
flexibility to the C-terminus. The RGD and RAD peptide fibrils gave identical small- and wide-angle x-
ray scattering patterns,13 indicating that the single amino-acid difference does not affect the core fibril 
structure, although interestingly, it does alter the kinetics of assembly and seeding behaviour.15 The 
RGDS variant does indeed exhibit cell-binding, and small-angle x-ray scattering measurement of beta-
sheet widths suggested that both 17-residue peptide variants were not wholly in the cross-beta 
confirmation, consistent with expectation.13 Moreover, the thermodynamic stability of the RGDS variant 
is the same as that of YTIALLSPYS, the eleven residues of the N-terminus16, suggesting that the C-
terminus does not contribute to the hydrogen bonding that holds together the cross-beta core. However, 
no more precise details of the chimeric structure were demonstrated, due to the difficulty in obtaining 
residue-specific information. 
We synthesised 13C18O alanine from the commercially obtained 13C labelled amino acid; the oxygen 
labelling was carried out following Arkin’s protocol.14,17 The method yielded approximately 70% 
labelling (see mass spectra in Supporting Information). Two peptide variants with the sequence 
YTIAALLSPYSGGRADS were synthesised using standard Fmoc solid-phase synthesis techniques,18 
incorporating the 13C18O-labelled amino-acid into position 5 or 15. We denote these 
YTIAA*LLSPYSGGRADS and YTIAALLSPYSGGRA*DS respectively. The mass of each peptide was 
confirmed  by electrospray mass spectrometry which showed a dominant peak at the expected mass of 
1743.9 Da (3 Da higher than the expected monoisotopic mass for the unlabelled peptide); each sample 
was >97% pure following purification by high performance liquid chromatography. Fibrils were formed 
following published methods13 by dissolving the solid peptides in a solution of 90% water (purified to a 
resistivity of 18.2 mΩ) and 10% acetonitrile at a concentration of 10 mg/mL. The solutions were vortex 
mixed for 10 minutes and incubated at 37 °C for 24 hours followed by incubation at room temperature for 
at least 4 weeks. The two different labelled peptides form fibrils adopting the same morphology as one 
another, and as the unlabelled peptide fibrils published previously,13 as shown by the transmission 
electron micrographs and fiber x-ray diffraction patterns shown in Figure 1. The diffraction patterns both 
show axial and equatorial reflections at approximately 4.7 and 8.9 Å respectively (exact values given in 
figure legend), in agreement with the unlabelled fibrils,13 demonstrating the characteristic cross-beta 
structure with 4.7 Å between strands and 8.9 Å between beta-sheets. The isotope label itself therefore 
does not affect the fibrils’ internal structure. 
 
  
Figure 1: TEM images (left) and fiber x-ray diffraction patterns (right) of fibrils formed from 
YTIAA*LLSPYSGGRADS (top) and YTIAALLSPYSGGRA*DS. (bottom). Equatorial reflections are at 
8.88 ± 0.06 Å and 8.86 ± 0.03 Å respectively. Axial reflections are at 4.72 ± 0.03 Å in both samples.  In 
both x-ray diffraction patterns, the fibril alignment direction is vertical. Both TEM images are shown 
at the same magnification. 
 
Unpolarised infrared spectra of dried films of the two different labelled peptide fibrils are shown in Figure 
2, together with a spectrum from the unlabelled sample. All samples show an intensity maximum in the 
amide I region at about 1630 cm-1, as expected from the high beta-sheet content of the fibrils.19 There are, 
however, significant differences that emerge as a result of the labelled alanine residue. Most importantly, 
both labelled samples show the additional red-shifted 13C18O stretch at around 1590 cm-1 (illustrated 
with a star in the figure). Other differences can be seen in the amide I region, especially for the peptide 
labelled in position Ala-5, YTIAA*LLSPYSGGRADS. This is most probably due to the presence of the 
label disrupting the coupling between the unlabelled oscillators,12 suggesting that Ala-5 lies within the 
extended beta-sheet region.  
  
Figure 2:  FTIR spectra of fibrils formed from labelled and unlabelled YTIAALLSPYSGGRADS. The 
CO stretch from the labelled residues, marked with a star in the figure, is visible at approximately 1590 
cm-1. Spectral intensities are scaled with respect to the amide I band.  
In order to analyse the orientation of the labelled 13C18O groups, aligned films of the two different labelled 
peptide fibrils were prepared using a molecular combing technique that we have described previously.8 
Briefly, 10 µL droplets of fibril suspension were blown along individual CaF2 IR windows using a stream 
of air, which induces fibril alignment in the flow direction. Polarised infrared spectra were then obtained 
parallel and perpendicular to this axis. The spectra are shown in Figure 3. For both samples, differences 
between the orthogonally polarised spectra demonstrate some degree of overall sample alignment. In 
particular, the peaks at around 3280, 1630 and 1540 cm-1 corresponding to the Amide A, unlabelled 
Amide I and Amide II vibrations respectively show positive, positive and negative peaks in the (parallel-
perpendicular) difference spectra. The Amide A NH stretch and Amide I CO stretch are therefore oriented 
parallel to the fibril axis, while the Amide II, which is predominantly a stretch along the beta-strand, is 
oriented perpendicular to it. This is to be expected for a cross-beta structure.8 
In the YTIAA*LLSPYSGGRADS sample, the 1587 cm-1 band from the labelled Ala-5 residue shows 
significant positive dichroism, indicating that the 13C18O group is close to parallel to the fibril axis, and 
therefore that it too is incorporated into the extended cross-beta structure.  
 
Figure 3: Polarised infrared spectra of aligned fibrils from YTIAA*LLSPYSGGRADS (top) and 
YTIAALLSPYSGGRA*DS (bottom), showing full spectra (left) and amide I and II region (right). 
Difference spectra are defined as parallel minus perpendicular, and are scaled with respect to the 
amide I difference peak. 
In contrast, the band from the labelled Ala-15 residue in the YTIAALLSPYSGGRA*DS sample shows 
no significant difference between the two different polarisations. This indicates that its 13C18O group is 
either disordered, or else oriented close to the magic angle20 of arccos(1/√3), approximately 55° from the 
fibril axis. We believe that a disordered structure, due to the flexibility of the GG residues, is more 
plausible. This is particularly significant in light of the suggestions that the C-terminus influences the 
kinetics15 but not the thermodynamics16 of the formation of these fibrils.  
A proposed structure is illustrated in Figure 4. This is depicted assuming that the peptide strands are 
parallel rather than anti-parallel, an assumption based on previous suggestions for 
YTIAALLSPYSGGRADS13 and the fact that this arrangement has been demonstrated for 
YTIAALLSPYS21. 
  
Figure 4: Suggested structure for YTIAALLSPYSGGRADS peptide in a fibril. 
Conclusions 
Our data confirm that the YTIAALLSPYSGGRADS peptides adopt a chimeric structure in the fibrils, as 
suggested by previously published x-ray scattering data.13 The novel combination of molecular combing, 
polarised spectroscopy and isotope labelling elucidate the nature of this structure, whereby the ordered 
cross-beta structure is adopted only by the N-terminal part of the peptide.  
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Graphical Abstract 
  
Textual Abstract 
Local disorder at the C terminus of a functional fibril-forming peptide is revealed by a novel combination 
of site-specific 13C-18O labeling, and infrared linear dichroism spectroscopy applied to fibrils 
macroscopically oriented by molecular combing 
